ADMA Biologics Inc

27 de ago. de 2026, 19:11 UTC

ADMA Biologics Inc. shares are lower today amid pressure on biotechnology stocks, despite a brief uptick earlier in the session. No specific news was identified.

26 de ago. de 2026, 20:08 UTC

ADMA Biologics Inc. shares are lower amid biotechnology sector weakness, with no specific news identified to explain the decline.

25 de ago. de 2026, 19:26 UTC

ADMA Biologics shares are higher today, supported by declining U.S. Treasury yields that typically enhance equity valuations. No specific company news was identified.

24 de ago. de 2026, 20:06 UTC

ADMA Biologics Inc shares are lower during Monday's session, reversing earlier gains amid broader market influences, including rising oil prices and geopolitical tensions.

21 de ago. de 2026, 23:01 UTC

ADMA Biologics Inc shares declined in after-market trading, continuing a trend of lower finishes over the past three sessions amid broader market volatility.

20 de ago. de 2026, 20:06 UTC

ADMA Biologics Inc shares are lower in Thursday's session, with no specific news identified. Broader market declines may be influencing sentiment amid rising Treasury yields.

19 de ago. de 2026, 20:01 UTC

ADMA Biologics Inc shares are higher Wednesday, continuing a strong upward trend since Tuesday's close, despite no specific news driving the move.

17 de ago. de 2026, 19:36 UTC

ADMA Biologics is trading lower amid an investigation into potential fiduciary breaches by its Board of Directors. Broader market sentiment may also be impacting shares.

13 de ago. de 2026, 20:02 UTC

ADMA Biologics shares are lower amid concerns over financial practices and potential SEC scrutiny, despite claims of an internal review clearing the company.

12 de ago. de 2026, 19:46 UTC

ADMA Biologics shares are trading lower today, despite broader market gains following a positive inflation report. The stock remains near its one-month high.

11 de ago. de 2026, 22:56 UTC

ADMA Biologics Inc shares are lower in after-market hours following an earlier decline. The price remains above its 20-day moving average.

7 de ago. de 2026, 19:46 UTC

ADMA Biologics shares are lower following a securities fraud class action lawsuit alleging false statements and undisclosed transactions, amid broader negative market sentiment.

6 de ago. de 2026, 20:02 UTC

ADMA Biologics reported second-quarter net income of $37.82 million and revenue of $124.40 million, driving shares higher during Thursday's session.

5 de ago. de 2026, 23:02 UTC

ADMA Biologics reported second-quarter revenue of $124.4 million, missing expectations. Shares are lower in after-market trading following the earnings release.

4 de ago. de 2026, 19:46 UTC

ADMA Biologics Inc. is trading higher, buoyed by strong momentum and a decline in crude oil prices that eases inflation concerns and supports consumer spending.

3 de ago. de 2026, 19:16 UTC

ADMA Biologics Inc shares are higher today, continuing an upward trend since Friday amid broader market optimism following recent geopolitical developments.

31 de jul. de 2026, 20:06 UTC

ADMA Biologics is declining amid a class action lawsuit alleging fraudulent activities, continuing a trend of four consecutive lower sessions.

30 de jul. de 2026, 19:39 UTC

ADMA Biologics shares are lower following a decline in first-quarter performance, reflecting broader market sentiment amid ongoing investor concerns.

29 de jul. de 2026, 18:17 UTC

ADMA Biologics will report second-quarter 2026 results on August 5, contributing to today's higher share price amid steady trading.

28 de jul. de 2026, 20:06 UTC

ADMA Biologics Inc. is rising amid broader biotechnology sector strength, despite ongoing legal challenges. The stock has shown steady gains since Monday's close.

27 de jul. de 2026, 19:41 UTC

ADMA Biologics Inc shares are higher today, continuing a strong performance since Friday. No specific news was identified to explain the gains.

24 de jul. de 2026, 19:26 UTC

ADMA Biologics shares are lower amid a securities fraud lawsuit alleging inflated revenue growth and related party transactions, impacting investor sentiment.

22 de jul. de 2026, 18:36 UTC

ADMA Biologics shares are lower as a class action lawsuit targets investors, alleging false statements about business practices and internal controls.

21 de jul. de 2026, 19:36 UTC

ADMA Biologics Inc faces a class action lawsuit alleging securities fraud, contributing to its decline since Monday's close. Shares briefly rebounded earlier in the session.

20 de jul. de 2026, 19:46 UTC

ADMA Biologics Inc shares are higher during Monday's session, despite fluctuations and no specific news to explain the price action since Friday's close.